Baxa Corporation Announces Safe Handling and Preparation of Hazardous Drugs Course Offering at its STAR Center Trainin... ( ENGLEWOOD Colo. March 17 /- Baxa ...)

HOME >> MEDICINE >> NEWS

Baxa Corporation Announces Safe Handling and Preparation of Hazardous Drugs Course Offering at its STAR Center Training Facility

Date:3/17/2008

ENGLEWOOD, Colo., March 17 /PRNewswire/ -- Baxa Corporation announces the latest addition to its STAR (Skills Training, Academics and Resources) Center course offerings. Safe Handling and Preparation of Hazardous Drugs has been developed for nurses, pharmacists and physicians that prepare, handle or administer hazardous drugs. The 10-hour course combines hands-on experience with regulatory compliance and industry best practice to provide the most complete training in hazardous drug compounding and safe handling available.

Baxa launches the first class on April 24-25, with subsequent course dates on June 19-20 and August 21-22. The course is designed for front-line pharmacists, technicians, nurses, physicians, pharmacy managers and nursing managers, covering concepts that affect hazardous drug policies and procedures, from engineering controls to the proper use of closed-system drug transfer devices. Course material focuses on proper aseptic techniques and the principles and requirements of hazardous drug (HD) waste and disposal. Baxa developed the core curriculum with subject matter experts in HD, environmental consulting and USP < 797 > to prepare professionals for the Chapter guideline changes announced in December 2007.

"We're excited to have experts Eric Kastango and Luci Power at the STAR Center for the new HD course," said Marian Robinson, Baxa VP of Marketing. "Both have been leaders in the development of best-practice guidelines and have extensive experience in the rules and regulations placed on pharmacies and caregivers by governing bodies such as NIOSH, OSHA, USP, ONS and ASHP." STAR Center attendees are able to draw upon the knowledge and experience that the expert faculty brings. The program combines open discussion with hands-on learning to reinforce the principles that are presented during the classroom time.

The STAR Center was launched in fall of 2006 and regular classes have sold out each time they've been offered. Progr
'/>"/>

SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Sergeants(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation
2. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
3. STERIS Corporation Announces New $300 Million Share Repurchase Authorization
4. Dialysis Corporation of America Earnings Call Reminder
5. Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31, 2007 Results
6. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
7. Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement
8. Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. Providence Service Corporation and UnitedHealth Group Affiliate, OptumHealth Behavioral Solutions, Enter Into Strategic Relationship Agreement
11. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release

Post Your Comments:

(Date:12/1/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, The Future of Monoclonal Antibodies - ..., Product Pipeline and Deals Analysis ,, http...oclonal-Antibodies---Market-Forecasts-to-2015-Comp...alysis.html ,, Summary ,, The author has...

(Date:12/1/2009)...re-USNewswire/ -- The Kerlan Jobe Orthopaedic Clin...greed to pay the United States $3 million to settl...rom HealthSouth Corporation, the Justice Departmen...ves allegations that HealthSouth paid kickbacks to...onations to the Kerlan Jobe Foundation, loan forgi...

(Date:12/1/2009)...ewswire-USNewswire/ -- A scientist who broadened t...ways we can control and relieve it -- has won the ... Psychology. ,, Ronald Melzack, psychology prof...as selected for the award from among 24 nomination...ry but instead in their brain through a pathway th...

(Date:12/1/2009)...hs more likely, British study finds , , ... who are poor are more likely to deliver a very pr...oth groups typically receive equal care, a new Bri... research team said their findings show the need t...c status and preterm birth. , For the study, th...

(Date:12/1/2009)...iteria based on computed tomography (CT) imaging o...es after chemotherapy with the drug bevacizumab ma...according to a study in the December 2 issue of J...c (toxic to cells) chemotherapy is associated with...ectal cancer and higher pathologic response rates ...

[1] Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations [0] Scientist Who Helps Explain Pain Wins Grawemeyer Award [0] More Preemies Born Among the Poor [0] Criteria based on CT imaging after chemotherapy may help predict survival

...AN, Va., April 6 Improper food preparation habits...bits are not just found in food processing plants ...One third of the participants in a Dutch study of ...e used with the raw chicken, not washing their han...

...ta-based company allows patients to hold their pla...nt care centers , , ATLANTA, April 6 InQuickER,...p, Inc., one of the Southeast,s most reputable pub...as it pursues national recognition as a first move...

...TOWN, South Africa, April 6 Expanding therapeutic...growth within the Kenyan pharmaceutical industry. ... for the largest burden of disease in Kenya, non-c...(Logo: http://www.newscom.com/cgi-bin/prnh/20081...

... In an effort to educate Americ...tress and to bring awareness to proactive strategi... Awareness month. Internet retailer Magazines.com ...009 -- Knowing the difference between good stress ...

... Premier Plastic Surgery, Pitt...urgery Center welcome Ana C. Busquets, MD, FAAD, B... Upper St. Clair, PA (Vocus) April 5, 2009 ...urgery medical spas offering a wide range of medic...

...ple customer agreements for Soarian Clinicals and ... a banner year for the system that streamlines the...patient-safety initiatives. , , CHICAGO, April 5 ...for its enterprise-wide clinical workflow system...

Other Medicine News:Health News:Good Kitchen Practices Can Keep You and Your Children From Getting Sick 2 Health News:Imagine No More Waits for Emergency Room Care ... InQuickER Chooses Trevelino/Keller Communications to Launch First Service of Its Kind 2 Health News:Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan 2 Health News:Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan 3 Health News:Cope with Recession-Related Stress with a Lifestyle Magazine Subscription 2 Health News:Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations 2 Health News:Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations 3 Health News:Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations 4 Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 2 Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 3 Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 4

Good Kitchen Practices Can Keep You and Your Children From Getting Sick Imagine No More Waits for Emergency Room Care ... InQuickER Chooses Trevelino/Keller Communications to Launch First Service of Its Kind Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan Cope with Recession-Related Stress with a Lifestyle Magazine Subscription Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009

(Date:12/1/2009)..., Mass. and TOKYO, Dec. 1 Galenea ...d today the further extension of their research an...test extension increases the collaboration term to...g to approximately $90 million. The companies hav...e goal of discovering and developing first-in-clas...

(Date:12/1/2009)...R, Fla., Dec. 1 CCS Medical, Inc. ...upplies, today announced that it has received appr...istrict of Delaware (the "Court") for its bidding ...oposed sale of substantially all of its assets. ,...the Court approved bidding procedures for the sale...

(Date:12/1/2009)...K, Dec. 1 WebMD Health C...h information, today announced the honorees of the...l WebMD Health Heroes honor Americans with extraor...e, who lead an effort to help others achieve bette...om/cgi-bin/prnh/20091201/NY18114 ) ,, "WebMD i...

Breaking Medicine Technology:Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2 Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3 CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2 WebMD Announces 2009 Health Heroes 2 WebMD Announces 2009 Health Heroes 3 ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 1 ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 2 ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 3 ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 4 Statins May Cause Muscle Damage in Some Patients 50823 1 Statins May Cause Muscle Damage in Some Patients 50823 2 Statins May Cause Muscle Damage in Some Patients 50823 3 Lilly Sets Date and Conference Call for Second Quarter 2009 Financial Results Announcement 50821 1

[0] Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration [0] CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures [0] WebMD Announces 2009 Health Heroes

...t. 4 In an extensive analysis of,clinical trials ...eluting,Coronary Stent was associated with signifi... reintervention compared to the Taxus Stent out to...ta-analysis of 16 randomized,clinical trials and 8...,date, is now posted on the Journal of the America...

...s From Its Metabolic Disease Program In Clinical ..., Calif., Sept. 4 Isis,Pharmaceuticals, Inc. (Nas...ase 1 study of ISIS 325568, an antisense drug desi...with type 2 diabetes by inhibiting production,of t...at binds glucagon, a,hormone that opposes the acti...

Other Medicine Technology:Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2 Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3 Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4 Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes 2 Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes 3

Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes

...s a basic laboratory system for pH and temperature...can be obtained when used with a temperature probe... one and two-point calibration with Auto-Find auto..., 4.00, 7.00, 10.01 and 12.45) and Auto-Read for l...

...- the multifunctional high-end microplate reader w...ading detection modes., Fluorescence Intensity -... Fluorescence - HTRF, AlphaScreen , Luminescence ... microplate reader with fastest read times. The ul...

Safire 2

...or Ultra High Throughput Screening (UHTS), Analyst... performance. Allows for smooth transfer of assays...all the detection modalities of Analyst AD and HT,..., time-resolved fluorescence, luminescence, absorb...

Medicine Products:

F 340 pH / Temp Meter, 220V, Euro Plug PHERAstar Safire 2 Analyst GT with Integrated Stacker

Baxa Corporation Announces Safe Handling and Preparation of Hazardous Drugs Course Offering at its STAR Center Trainin...( ENGLEWOOD Colo. March 17 /- Baxa ...),Health